Cost studies once again topped the list making up 33.55% of all studies. There was less of an even distribution in the International meeting as the top four types of studies made up 83.42% of all studies as opposed to the European meeting were the top four studies made up 72.90% of all studies.
Regulation of healthcare studies saw a significant increase in the International meeting making up 1.60% of all studies while only making up 0.42% in the European meeting. Lastly, there were zero risk-sharing posters in the International meeting and five in the European meeting. This may be reflective of the lack of uptake in these types of contracts outside of Europe.
Workshops and Issue Panels
Another way to identify trends in the industry are through the issue panels and workshops. Since ISPOR members submit their own ideas for issues panels and workshops, it can provide a good beat of where things are heading. Unlike posters which often reflect completed studies, workshops and issues panels may provide better insight on the direction of the field.
We compiled a word cloud for both the panels and workshops. The issue panel’s cloud is found below.
For the most part, the most popular words contained in the titles are predictable as health care, new, technology and time. A few interesting trends emerged with real world, personalized data, personalizing, and risk-sharing.
There seems to be a good amount of focus being put around the new personalized medicines and available data along with risk-sharing and, of course, all of the new real world data becoming available.
Below we have done the same thing for the workshops.
The workshops seem to be a bit more directed as a “how to” instead of issue panels, which are directed more so at understand the issue and its implications. These “how to” workshops are mostly involved with outcomes, data, and research which are all fully expected and not out of the ordinary.
A couple of the more interesting words being used in the workshops was electronic and EMR. There were two workshops having electronic medical records as their focus:
- A REALISTIC APPROACH TO WORKING WITH ONCOLOGY ELECTRONIC MEDICAL RECORD (EMR) DATA IN OUTCOMES RESEARCH
PATIENT-REPORTED OUTCOMES (PROs) – USE IN ELECTRONIC MEDICAL RECORDS (EMR) AND IMPLICATIONS FOR COMPARATIVE EFFECTIVENESS RESEARCH (CER)
We expect more of these types of workshops in the future as EMR data becomes more widespread. This data will eventually become another asset to health economists.